RaySearch Laboratories AB (LTS:0GRZ) FFO


LTS:0GRZ RaySearch Laboratories AB LTS:0GRZ
83 GF Score
Price kr232.20
GF Value kr188.99
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0GRZ
83GF Score
RaySearch Laboratories AB LTS:0GRZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is RaySearch Laboratories AB (LTS:0GRZ) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of kr232.20 is trading 22.9% above its estimated GF Value™ of kr188.99. GuruFocus considers RaySearch Laboratories AB to be Modestly Overvalued.

Key valuation signals for LTS:0GRZ:

  • FFO:
  • GF Value™: kr188.99 vs. price of kr232.20 (22.9% above fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the LTS:0GRZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
83GF Score

Get the complete analysis for LTS:0GRZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr232.20
Price
kr188.99
GF Value